24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
LEUCOLIEVA 300 MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | LEUCOLIEVA 300 MG |
|---|---|
| Composition | Leucovorin Calcium Injection USP 300mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
LEUCOLIEVA 300 MG (Leucovorin Calcium Injection USP 300mg) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
LEUCOLIEVA 300 MG (Leucovorin Calcium Injection USP 300 mg) is a prescription medication containing Leucovorin Calcium 300 mg, a reduced form of folic acid used in oncology and supportive cancer care. Leucovorin plays a crucial role in reducing the toxic effects of certain chemotherapy medicines, particularly high-dose Methotrexate, while also enhancing the effectiveness of selected anticancer treatments. It is widely used in hospitals, oncology centers, and specialized healthcare facilities as part of comprehensive cancer treatment protocols.
Leucovorin Calcium is commonly referred to as Folinic Acid and differs from regular folic acid because it can be utilized directly by the body without requiring activation. This property makes it particularly valuable in patients undergoing chemotherapy, where it helps protect healthy cells from the harmful effects of certain medications while allowing cancer treatment to remain effective.
LEUCOLIEVA 300 MG is frequently used in Methotrexate Rescue Therapy, a treatment strategy designed to minimize toxicity after high-dose Methotrexate administration. By supplying healthy cells with a usable form of folate, Leucovorin helps reduce damage to normal tissues and supports recovery from chemotherapy-related side effects.
In addition to its protective role, Leucovorin is also used in combination with 5-Fluorouracil (5-FU) to enhance the anticancer activity of the chemotherapy regimen. This combination is commonly prescribed in the treatment of colorectal cancer and other gastrointestinal malignancies.
LEUCOLIEVA 300 MG is commonly prescribed for:
The medicine should only be administered by qualified healthcare professionals experienced in oncology and chemotherapy management.
Manufactured under stringent pharmaceutical quality standards, LEUCOLIEVA 300 MG is designed to ensure consistent quality, safety, and therapeutic effectiveness.
Patients receiving Leucovorin therapy may require regular clinical monitoring, laboratory testing, and ongoing assessment to ensure optimal treatment outcomes and patient safety.
Due to its essential role in chemotherapy support and cancer treatment optimization, LEUCOLIEVA 300 MG remains an important medicine in modern oncology practice worldwide.
LEUCOLIEVA 300 MG (Leucovorin Calcium Injection USP 300 mg) is used in cancer treatment, supportive oncology care, and selected medical conditions requiring folinic acid supplementation.
The medicine is widely used to reduce the toxic effects of high-dose Methotrexate treatment.
Leucovorin is commonly combined with 5-Fluorouracil to improve treatment effectiveness in colorectal cancer.
The medicine may be used in various gastrointestinal cancer treatment protocols.
It helps protect healthy cells from certain chemotherapy-related toxicities.
In selected clinical situations, Leucovorin may be used to address folate deficiency.
The medicine supports multiple chemotherapy regimens used in cancer treatment.
Leucovorin plays an important role in comprehensive oncology management strategies.
Leucovorin Calcium belongs to a class of medicines known as Folate Analogues.
LEUCOLIEVA works by:
This dual role makes Leucovorin an essential medicine in modern oncology treatment protocols.
Like all medicines, LEUCOLIEVA 300 MG may cause side effects in some patients. However, many patients tolerate the medicine well when administered under medical supervision.
Some patients may experience mild nausea during treatment.
Occasional vomiting may occur in certain individuals.
Patients may experience tiredness or weakness.
Pain, redness, or mild irritation at the injection site may occur.
Mild fever may occasionally develop after administration.
Some individuals may experience gastrointestinal symptoms.
Mild skin rash or itching may occur in rare cases.
Seek immediate medical attention if you experience:
Patients should contact their healthcare provider immediately if serious side effects occur.
The dosage of LEUCOLIEVA 300 MG (Leucovorin Calcium Injection USP 300 mg) should always be determined by a qualified healthcare professional.
Dosage differs depending on whether the medicine is used for Methotrexate rescue or chemotherapy enhancement.
The specific cancer treatment protocol influences dosage and administration schedules.
Overall health status and treatment response play a role in determining dosage.
Blood tests and clinical assessments help guide treatment planning.
Previous treatments and individual patient factors may influence dosing decisions.
Before receiving treatment, patients should inform their doctor if they have:
Patients should also disclose all prescription medicines, supplements, and herbal products they are currently taking to avoid potential drug interactions.
Pregnant or breastfeeding women should only receive this medicine if specifically recommended by a healthcare professional.
It is primarily used for Methotrexate rescue therapy, chemotherapy support, and in combination with certain anticancer medicines such as 5-Fluorouracil.
Leucovorin Calcium is an active form of folic acid (folinic acid) used to reduce chemotherapy toxicity and support cancer treatment protocols.
It is mainly used as supportive therapy and to enhance the effectiveness of certain chemotherapy regimens rather than acting as a standalone cancer treatment.
It helps protect healthy cells and reduces the toxic effects associated with high-dose Methotrexate therapy.
Yes, it is frequently used as part of combination chemotherapy protocols.
Yes, doctors typically recommend laboratory testing and clinical assessments throughout treatment.
Its use depends on the treatment protocol and should always be guided by a qualified healthcare professional.
Yes, this medicine should only be administered by qualified healthcare professionals experienced in oncology, chemotherapy, and supportive cancer care.